A new study finds that people with systemic lupus erythematosus-related thrombocytopenia (SLE-TP) who have antiphospholipid antibodies (aPLs) in their blood are more likely to have more severe disease ...

A new study identifies eight domains of active systemic #lupus erythematosus for defining meaningful treatment response in ...

DelveInsight's B-cell Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast report includes a comprehensive understanding of current treatment practices, addressable ...

(MENAFN- GlobeNewsWire - Nasdaq) Clinical Trials of Budoprutug in Primary Membranous Nephropathy (pMN), Immune Thrombocytopenia (ITP), and Systemic Lupus Erythematosus (SLE) on Track to Initiate ...

Systemic lupus erythematosus (SLE) is a chronic autoimmune condition that causes widespread inflammation. It can affect the skin, joints, blood vessels, and multiple organ systems. The exact cause ...

A new analysis suggests that about 400,000 people globally receive a systemic lupus erythematosus (SLE) diagnosis each year and that most of these people are women. However, the study also showed ...

Treatment for autoimmune diseases such as systemic lupus erythematosus (SLE), idiopathic inflammatory myositis, and systemic sclerosis often involves long-term immune suppression. Resetting ...

Systemic lupus erythematosus (SLE) is the most common type of lupus, a chronic autoimmune disease. Symptoms include fatigue, joint pain, and rashes across your nose and cheeks. While there’s no ...

Symptoms can range from mild to life-threatening. Systemic lupus erythematosus (SLE) is the most common type, and people often use the term lupus to refer to SLE. However, there are other types ...